We have over 12,000 students, from over 100 countries, within one of the safest campuses in the UK


97% of Lancaster students go into work or further study within six months of graduating

Home > Research > Publications & Outputs > The Silent “G”: A Case Study in the Production ...
View graph of relations

« Back

The Silent “G”: A Case Study in the Production of “Drugs” and “Drug Problems”

Research output: Contribution to journalJournal article


<mark>Journal publication date</mark>2012
<mark>Journal</mark>Contemporary Drug Problems
Number of pages26
<mark>Original language</mark>English


ConferenceContemporary Drug Problems Conference: Beyond the Buzzword: Problematising ‘Drugs’


This paper focuses on ‘G’ in the United Kingdom (UK), G being the collective term for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL). Drawing on empirical data and taking a critical drug studies perspective, we use G as a case study in how drug cultures move through phases whereby a diffuse and contested network of emergent practices, agencies and processes become progressively ordered into a more stable and conventional set of problems and actors, here G and the ‘G problem’. The production of former ‘legal high’ G as a particular kind of drug in this network has shaped its relative neglect within UK research, policy and practice as compared to mephedrone, another former ‘legal high’. Our case study supports the longstanding observation that researchers, policy-makers and practitioners contribute to the performative and material constitution of ‘drugs’ and ‘drug problems’, upon which we reflect in our conclusion.

Related projects